US Patent Issued to XIAMEN VIVOHEALTHS TECHNOLOGY on July 7 for "Substituted fluorine-containing imidazole salt compound, preparation method therefor, pharmaceutical composition thereof and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,921, issued on July 7, was assigned to XIAMEN VIVOHEALTHS TECHNOLOGY Co. LTD. (Xiamen, China).

"Substituted fluorine-containing imidazole salt compound, preparation method therefor, pharmaceutical composition thereof and use thereof" was invented by Xianming Deng (Xianmen, China), Shengcai Lin (Xianmen, China) and Chensong Zhang (Xianmen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed in the invention are a type of compounds having activity of activating 5'-adenosine monophosphate-activated protein kinase (AMPK), a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the m...